Weekly Readout

A digest of new clinical data from the past week.

Weekly Readout

Genmab scores two cancer wins, CAR-T unravels AL amyloidosis, and more

Oct 9, 2026

•

24 min read

Genmab scores two cancer wins, CAR-T unravels AL amyloidosis, and more

Weekly Readout #25: Week ending October 9, 2026

Biotech Readout

Weekly Readout

Oct 7, 2026

•

19 min read

EADV 2026

Breakthroughs from Europe's largest dermatological conference

Biotech Readout

Weekly Readout

Oct 2, 2026

•

25 min read

EASD 2026

Breakthroughs & debates from Europe's largest diabetes conference

Biotech Readout

Weekly Readout

Pharma voices urgent concerns about degrading EU innovation, Viking maintains weight loss with less frequent dosing, and more

Sep 25, 2026

•

23 min read

Pharma voices urgent concerns about degrading EU innovation, Viking maintains weight loss with less frequent dosing, and more

Weekly Readout #24: Week ending September 25, 2026

Biotech Readout

Weekly Readout

China publishes 5-year plan for biotech, Definium secures 2nd anxiety win, and more

Sep 18, 2026

•

11 min read

China publishes 5-year plan for biotech, Definium secures 2nd anxiety win, and more

Weekly Readout #23: Week ending September 18, 2026

Biotech Readout

Weekly Readout

Sep 16, 2026

•

22 min read

WCLC 2026

Breakthroughs from the world’s largest lung cancer conference

Biotech Readout

Weekly Readout

Roivant's respiratory win, Beam rewrites a gene, and more

Sep 11, 2026

•

20 min read

Roivant's respiratory win, Beam rewrites a gene, and more

Weekly Readout #22: Week ending September 11, 2026

Biotech Readout

Weekly Readout

RevMed's pancreatic cancer medicine posts early results in lung cancer, GSK enters mRNA vaccine space, and more

Sep 4, 2026

•

17 min read

RevMed's pancreatic cancer medicine posts early results in lung cancer, GSK enters mRNA vaccine space, and more

Weekly Readout #21: Week ending September 4, 2026

Biotech Readout

Weekly Readout

Sep 1, 2026

•

23 min read

ESC 2026

Breakthroughs and debates from Europe's largest cardiology conference

Biotech Readout

Weekly Readout

RevMed's pancreatic cancer medicine approved, Eli Lilly's GLP1-GIP tirzepatide prevents heart attack & stroke, and more

Aug 28, 2026

•

19 min read

RevMed's pancreatic cancer medicine approved, Eli Lilly's GLP1-GIP tirzepatide prevents heart attack & stroke, and more

Weekly Readout #20: Week ending August 28, 2026

Biotech Readout

Weekly Readout

Moderna's cancer vaccine makes a splash, Amylyx returns with anti-GLP1, and more

Aug 21, 2026

•

17 min read

Moderna's cancer vaccine makes a splash, Amylyx returns with anti-GLP1, and more

Weekly Readout #19: Week ending August 20, 2026

Biotech Readout

Weekly Readout

Biotechs post wins in menopause hot flashes, anxiety disorder, polycythemia vera, and more

Aug 14, 2026

•

9 min read

Biotechs post wins in menopause hot flashes, anxiety disorder, polycythemia vera, and more

Weekly Readout #18: Week ending August 14, 2026

Biotech Readout

Weekly Readout

Surprise approvals of Replimune's RP1 & Moderna's flu vaccine, orexin unlocks narcolepsy, and more

Aug 7, 2026

•

11 min read

Surprise approvals of Replimune's RP1 & Moderna's flu vaccine, orexin unlocks narcolepsy, and more

Weekly Readout #17: Week ending August 7, 2026

Biotech Readout

Weekly Readout

Obesity drug treats alcoholism, a China-originated drug pursues $30 billion market, and more

Jul 31, 2026

•

12 min read

Obesity drug treats alcoholism, a China-originated drug pursues $30 billion market, and more

Weekly Readout #16: Week ending July 31, 2026

Biotech Readout

Weekly Readout

GSK-Nuvalent buyout bears fruit, diabetic obesity drug raises the bar, and more

Jul 24, 2026

•

12 min read

GSK-Nuvalent buyout bears fruit, diabetic obesity drug raises the bar, and more

Weekly Readout #15: Week ending July 24, 2026

Biotech Readout

Weekly Readout

Approvals for cholesterol-lowering and breast cancer, another tau attempt in Alzheimer's, and more

Jul 17, 2026

•

14 min read

Approvals for cholesterol-lowering and breast cancer, another tau attempt in Alzheimer's, and more

Weekly Readout #14: Week ending July 17, 2026

Biotech Readout

Weekly Readout

First positive Phase 3's for B7-H3 in cancer and psilocybin in depression, and more

Jul 10, 2026

•

10 min read

First positive Phase 3's for B7-H3 in cancer and psilocybin in depression, and more

Weekly Readout #13: Week endings July 10, 2026

Biotech Readout

Weekly Readout

Abivax addresses safety, first Treg approval, and more

Jul 3, 2026

•

20 min read

Abivax addresses safety, first Treg approval, and more

Weekly Readout #12: Week ending July 3, 2026

Biotech Readout

Weekly Readout

China achieves world's first CAR-T approval for solid tumors, green shoots in neuropsych, and more

Jun 26, 2026

•

14 min read

China achieves world's first CAR-T approval for solid tumors, green shoots in neuropsych, and more

Weekly Readout #11: Week ending June 26, 2026

Biotech Readout

Weekly Readout

First approval in recently diagnosed T1D, gene therapy rewrites HAE, and more

Jun 19, 2026

•

12 min read

First approval in recently diagnosed T1D, gene therapy rewrites HAE, and more

Weekly Readout #10: Week ending June 19, 2026

Biotech Readout

Weekly Readout

Jun 12, 2026

•

6 min read

ADA 2026

Summer's hottest obesity & diabetes conference

Biotech Readout

Weekly Readout

Jun 7, 2026

•

21 min read

EULAR 2026

Reviewing innovation from Europe's largest immunology conference

Biotech Readout

Weekly Readout

Jun 5, 2026

•

15 min read

ASCO 2026 Awards

Major survival wins in pancreatic, breast, and skin cancer

Biotech Readout

Weekly Readout

Obesity drugs for cancer, deleting cholesterol, Hepatitis B functional cure, and more

May 29, 2026

•

21 min read

Obesity drugs for cancer, deleting cholesterol, Hepatitis B functional cure, and more

Weekly Readout #9: Week ending May 29, 2026

Biotech Readout

Weekly Readout

>30% weight loss, new blood pressure drug, FcRn cracks rheumatoid arthritis, and more

May 22, 2026

•

22 min read

>30% weight loss, new blood pressure drug, FcRn cracks rheumatoid arthritis, and more

Weekly Readout #8: Week ending May 22, 2026

Biotech Readout